Track Myomo, Inc. — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

Myomo, Inc. MYO · Stock Open Myomo, Inc. in new tab

1.57 USD
EPS
-0.35
P/B
9.05
ROE
-123.76
Beta
1.50
Target Price
4.64 USD
Loading chart...
Key Metrics
Earnings dateNov. 9, 2026
EPS-0.35
Book Value0.15
Price to Book9.05
Debt/Equity344.47
% Insiders9.360%
Growth
Revenue Growth0.21%
Estimates
Forward P/E-6.05
Forward EPS-0.22
Target Mean Price4.64

DCF Valuation

Tweak assumptions to recompute fair value for Myomo, Inc. (MYO)
Currency: USD
DCF Assumptions
Decimal (e.g., 0.10 = 10%). Range allows declines (−50%) to strong growth (+50%).
Decimal (e.g., 0.30 = 30%).
Decimal (e.g., 0.04 = 4%).
Decimal (e.g., 0.20 = 20%).
Percent number (e.g., 3 = 3%).
Percent number (e.g., 10 = 10%).
Percent number (e.g., 5 = 5%).
DCF Result

Fair Value (DCF)
Current Price
Upside
WACC
Terminal PV
Σ PV of FCFs
Note: historical bars show reported FCF (for context); forward bars show PV of projected FCF; if no per-year data, totals are shown.

Myomo, Inc. Logo Myomo, Inc. Analysis (MYO)

United States Health Care Official Website Stock

Is Myomo, Inc. a good investment? Myomo, Inc. (MYO) is currently trading at 1.57 USD. Market analysts have a consensus price target of 4.64 USD. This suggests a potential upside from current levels.

Earnings Schedule: Myomo, Inc. is expected to release its next earnings report on Nov. 9, 2026. The market consensus estimate for Forward EPS is -0.22.

Investor FAQ

Does Myomo, Inc. pay a dividend?

No, it does not currently pay a dividend.

What asset class is Myomo, Inc.?

Myomo, Inc. is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.

When is the next earnings date?

The next earnings date is projected to be Nov. 9, 2026. The company currently has a trailing EPS of -0.35.

Company Profile

Myomo, Inc., a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States, Germany, and internationally. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient's weak or paralyzed arm to enable and improve functional activities of daily living. It also provides MyoPro 2 that includes control technology, configuration software and user interface, and pop-out battery for extended use of the brace; MyoPro2+, which comprises 3D printed orthotics capability, software enhancements, and a design for donning and doffing of the device; MyoGames, a virtual training platform; and MyoPro 2x Video Library. In addition, the company offers MyoCare, a post-delivery program that provides follow-up care with clients, therapists, and referral sources; MYOMO; MyoPal; and MyoCoach. Its products are designed to help adults and adolescents with neuromuscular conditions due to brachial plexus injury, stroke, traumatic brain injury, spinal cord injury, and other neurological disorders. The company sells its products through various sales channels, including orthotics and prosthetics providers, veteran's administration, and distributors. Myomo, Inc. was incorporated in 2004 and is headquartered in Burlington, Massachusetts.

Exchange Ticker
ASE (United States) MYO
Trades
Dividend History paid per year (USD)
No dividend history available.
Stock Splits
Split Date Split Ratio to 1
Jan. 31, 2020 0.03
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Fundamentals

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion